| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.17 | 0.0006 |
| mRNA | AT-406 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.002 |
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | -0.092 | 0.002 |
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | 0.099 | 0.003 |
| mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | -0.091 | 0.004 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.13 | 0.008 |
| mRNA | KIN001-135 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.01 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.13 | 0.01 |
| mRNA | YK 4-279 | GDSC1000 | pan-cancer | AAC | -0.079 | 0.03 |
| mRNA | Elesclomol | GDSC1000 | pan-cancer | AAC | -0.074 | 0.03 |